Artgen reported for 9 months of 2024 by RAS

Artgen Biotech's RAS net profit for 9 months of 2024 amounted to ₽220.7 million, up 3.5 times from ₽63.2 million in the previous year. Revenue rose 2.6 times to ₽114.9 million compared to ₽44.9 million a year earlier.